Similar articles for PMID: 31732854

Year	Number of Results
1997	3
1998	3
1999	2
2002	1
2003	1
2004	1
2005	3
2006	2
2007	3
2008	5
2009	4
2010	2
2011	8
2012	6
2013	8
2014	3
2015	11
2016	5
2017	10
2018	17
2019	10
2020	5
2021	7
2022	3
2023	1
2024	0

1

Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.

Sakamoto T, Saito Y, Kobayashi M, Yamada T, Takekuma Y, Nakai M, Ogawa K, Iseki K, Sugawara M. Sakamoto T, et al. Support Care Cancer. 2020 Jul;28(7):3251-3257. doi: 10.1007/s00520-019-05178-1. Epub 2019 Nov 16. Support Care Cancer. 2020. PMID: 31732854 Free article.

2

Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.

Sohara N, Takagi H, Abe T, Hashimoto Y, Kojima A, Takahashi H, Nagamine T, Mori M. Sohara N, et al. Support Care Cancer. 1999 Mar;7(2):84-8. doi: 10.1007/s005200050232. Support Care Cancer. 1999. PMID: 10089088

3

Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study.

Yang H, Seon J, Sung PS, Oh JS, Lee HL, Jang B, Chun HJ, Jang JW, Bae SH, Choi JY, Yoon SK. Yang H, et al. J Vasc Interv Radiol. 2017 Nov;28(11):1503-1511.e2. doi: 10.1016/j.jvir.2017.07.021. Epub 2017 Sep 21. J Vasc Interv Radiol. 2017. PMID: 28941589 Clinical Trial.

4

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.

Lucatelli P, Ginnani Corradini L, De Rubeis G, Rocco B, Basilico F, Cannavale A, Nardis PG, Corona M, Saba L, Catalano C, Bezzi M. Lucatelli P, et al. Cardiovasc Intervent Radiol. 2019 Jun;42(6):853-862. doi: 10.1007/s00270-019-02192-y. Epub 2019 Mar 6. Cardiovasc Intervent Radiol. 2019. PMID: 30843093 Free PMC article.

5

Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).

Nishio S, Aihara S, Shimokawa M, Fujishita A, Taniguchi S, Hachisuga T, Yanazume S, Kobayashi H, Murakami F, Numa F, Kotera K, Okura N, Toki N, Yokoyama M, Ushijima K. Nishio S, et al. J Gynecol Oncol. 2018 Sep;29(5):e77. doi: 10.3802/jgo.2018.29.e77. Epub 2018 May 15. J Gynecol Oncol. 2018. PMID: 30022637 Free PMC article. Clinical Trial.

6

[Impact of preventive administration of antiemetic drugs on risk of acute nausea and vomiting induced by transcatheter arterial chemoembolization in patients with hepatocellular carcinomas - a retrospective study].

Kabuki M, Higashihara H, Kakuda M, Fujita Y, Masuda J, Kin K, Ueguchi T, Osuga K, Tomiyama N. Kabuki M, et al. Gan To Kagaku Ryoho. 2013 Feb;40(2):197-201. Gan To Kagaku Ryoho. 2013. PMID: 23411955 Japanese.

7

A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.

Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Nagai K, Nakagawa T, Sugawara T, Hanaoka H, Kanai F, Yokosuka O. Ogasawara S, et al. Hepatology. 2018 Feb;67(2):575-585. doi: 10.1002/hep.29403. Epub 2017 Dec 23. Hepatology. 2018. PMID: 28746788 Clinical Trial.

8

Postembolization syndrome after hepatic transarterial chemoembolization: effect of prophylactic steroids on postprocedure medication requirements.

Kogut MJ, Chewning RH, Harris WP, Hippe DS, Padia SA. Kogut MJ, et al. J Vasc Interv Radiol. 2013 Mar;24(3):326-31. doi: 10.1016/j.jvir.2012.11.019. Epub 2013 Feb 4. J Vasc Interv Radiol. 2013. PMID: 23380736

9

Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.

Wu F, Lin X, Yang Z, Sun Z, Zeng F, Heng J, Qu J, Zeng L, Yang N, Zhang Y. Wu F, et al. Clin Lung Cancer. 2018 Nov;19(6):e913-e918. doi: 10.1016/j.cllc.2018.08.006. Epub 2018 Aug 23. Clin Lung Cancer. 2018. PMID: 30197265 Clinical Trial.

10

Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.

He JJ, Yin XX, Wang T, Chen MY, Li XL, Yang XJ, Shao HY. He JJ, et al. J Cancer Res Ther. 2021 Jul;17(3):777-783. doi: 10.4103/jcrt.jcrt_132_21. J Cancer Res Ther. 2021. PMID: 34269313 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year